Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Kjetil Taskén
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Kjetil Taskén, Hege E. G. Russnes, Ulla Randen, Ragnhild A. Lothe, Anne H. Ree, Geir E. Tjønnfjord, Hilde L. Nilsen, Sigbjørn Smeland & Åslaug Helland
Department of Pathology, Oslo University Hospital, Oslo, Norway
Hege E. G. Russnes, Tonje Lien, Pitt Niehusmann, Vigdis Nygaard, Anne Renolen, Bodil Bjerkehagen & Pitt Niehusmann
Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Hege E. G. Russnes, Tonje Lien & Åslaug Helland
Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway
Eline Aas
Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway
Eline Aas & Kåre B. Hagen
Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway
Line Bjørge
Centre for Cancer Biomarkers CCBIO, University of Bergen, Bergen, Norway
Line Bjørge & Bjørn T. Gjertsen
Department of Clinical Science, University of Bergen, Bergen, Norway
Line Bjørge, Bjørn T. Gjertsen, Olav K. Vintermyr, Gunnar Houge, Stian Knappskog, Per Eystein Lønning & Per E. Lønning
Department of Oncology, University Hospital of North Norway, Tromsø, Norway
Egil S. Blix, Fredrik Sund, Egil Blix & Tom Dønnem
Institute of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway
Egil S. Blix, Egil Blix & Tom Dønnem
Department of Research, Cancer Registry of Norway, Oslo, Norway
Giske Ursin & Espen Enerly
Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Gro L. Fagereng & Gro Live Fagereng
The Cancer Clinic, St. Olav University Hospital, Trondheim, Norway
Åsmund Flobak & Bjørn H. Grønberg
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Åsmund Flobak, Bjørn H. Grønberg & Ann-Charlotte Iversen
Department of Oncology, Stavanger University Hospital, Stavanger, Norway
Bjørnar Gilje
Haematology Section, Department of Medicine, Haukeland University Hospital, Bergen, Norway
Bjørn T. Gjertsen
Department of Oncology, Oslo University Hospital, Oslo, Norway
Tormod K. Guren, Sigmund Brabrand, Geir Olav Hjortland, Jon Amund Kyte & Åslaug Helland
CONNECT Public–Private Partnership, Oslo Cancer Cluster SA, Oslo, Norway
Jutta Heix, Steinar Ø. Thoresen & Ketil Widerberg
Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Eivind Hovig, Leonardo Meza-Zepeda & Leonardo A. Meza-Zepeda
Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway
Eivind Hovig
Section for Cancer Genomics, Haukeland University Hospital, Bergen, Norway
Randi Hovland, Hans-Rickard Brattbakk, Kari Ersland, Rakel Forthun, Hans Kristian Haugland & Olav K. Vintermyr
Department of Oncology, Haukeland University Hospital, Bergen, Norway
Åse Haug, Stian Knappskog, Per Eystein Lønning, Eli Sihn S. Steinskog & Per E. Lønning
Department of Core Facilities, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Susanne Lorenz, Daniel Vodak, Leonardo Meza-Zepeda & Leonardo A. Meza-Zepeda
Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway
Sigmund Brabrand, Pitt Niehusmann, Katarina Puco, Per M. Mæhle & Sigbjørn Smeland
Department of Clinical Molecular Biology, Akershus University Hospital, Lørenskog, Norway
Diana L. Bordin, Torben Lüders, John C. Noone & Hilde L. Nilsen
Merck AB NUF, Oslo, Norway
Steinar Ø. Thoresen
Roche Norge AS, Oslo, Norway
Terje C. Ahlquist, Ingvild Hagen, Kristin Krogsrud & Birgitte Lygren
Bayer AS, Oslo, Norway
Nyosha Alikhani
Bristol-Myers Squibb Norway Ltd NUF, Oslo, Norway
Ali Areffard & Gry Festervoll
Novartis Norge AS, Oslo, Norway
Eli Bergli & Petter Foss
Association of the Pharmaceutical Industry in Norway, Oslo, Norway
Hege Edvardsen & Monica Larsen
Norwegian Directorate of Health, Oslo, Norway
Grethe S. Foss
Pubgene AS, Oslo, Norway
Håvard H. Hauge
AstraZeneca AS, Oslo, Norway
Bjorn V. Herikstad
Department of Oncology, Nord-Trøndelag Hospital Trust, Levanger, Norway
Kristian Hveem & Olav T. D. Nguyen
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway
Kristian Hveem
HUNT Research Centre, Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Levanger, Norway
Kristian Hveem
AbbVie AS, Oslo, Norway
Elisabeth Jarnaess
MSD Norge AS, Oslo, Norway
Kristin Kittelsen
Amgen AB Norway NUF, Oslo, Norway
Mariam Lofwander
GlaxoSmithKline AS, Oslo, Norway
Aslaug Muggerud
Pfizer Norge AS, Oslo, Norway
Cathrine S. Notland
Norwegian Cancer Society, Oslo, Norway
Ole A. Oppdalshei
Eli Lilly Norge AS, Oslo, Norway
Ravinder Singh & Lars P. Strand
Department of Research, Stavanger University Hospital, Stavanger, Norway
Svein Skeie
Takeda AS, Oslo, Norway
Lidziya Ulvenes
Janssen-Cilag AS, Oslo, Norway
Sverrir Valgardsson
Unit for Medicine and Health Sciences, Akershus University Hospital, Lørenskog, Norway
Pål Wiik
NEC Corporation, Tokyo, Japan
Naoko Yamagata
Department of Clinical Pathology, University Hospital of North Norway, Tromsø, Norway
Thomas Berg, Ragnhild M. Wold & Kristin Åberg
Department of Pathology, Akershus University Hospital, Lørenskog, Norway
Richard Doughty & Ulla Randen
Department of Pathology, Stavanger University Hospital, Stavanger, Norway
Einar Gudlaugsson, Emiel Janssen & Sigmund V. Sperstad
Department of Oncology, Akershus University Hospital, Lørenskog, Norway
Hanne Hamre, Hanne Hamre & Anne H. Ree
Department of Pathology, Haukeland University Hospital, Bergen, Norway
Hans Kristian Haugland & Olav K. Vintermyr
Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway
Emiel Janssen
Department of Pathology, St. Olav University Hospital, Trondheim, Norway
Mari Jebens, Anne J. Skjulsvik & Sissel F. Wahl
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
Teresia Wangensteen
Department of Pathology, Nordland Hospital Trust, Bodø, Norway
Khalid Al-Shibli
Southern and Eastern Norway Pharmaceutical Trust, Oslo, Norway
Yvonne Andersson
Department of Oncology, Vestre Viken Hospital Trust, Drammen, Norway
Odd Terje Brustugun
Department of Oncology, Hospital of Southern Norway, Kristiansand, Norway
Marte G. Cameron
Department of Oncology, Nordland Hospital Trust, Bodø, Norway
Astrid Dalhaug
Department of Oncology, Telemark Hospital Trust, Skien, Norway
Dalia Dietzel
Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway
Ragnhild S. Falk
Department of Oncology, Fonna Hospital Trust, Haugesund, Norway
Sverre Fluge
IMPRESS-Norway Patient representative, Oslo, Norway
Kari Grønås
Department of Oncology, Innlandet Hospital Trust, Brumunddal, Norway
Daniel Heinrich & Hedda von der Lippe Gythfeldt
Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
Gunnar Houge
IMPRESS-Norway Patient representative, Trondheim, Norway
Ann-Charlotte Iversen
Department of Gynecological Oncology, Oslo University Hospital, Oslo, Norway
Kristina Lindemann
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
Ragnhild A. Lothe
Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund, Norway
Jo-Åsmund Lund
Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway
Monica C. Munthe-Kaas
Department of Pathology, Førde Hospital Trust, Førde, Norway
Tonje B. Riste
Department of Oncology, Vestfold Hospital Trust, Tønsberg, Norway
Karin Semb
Department of Oncology, Østfold Hospital Trust, Kalnes, Norway
Andreas Stensvold & Øyvind Tennøe
Department of Pathology, Vestfold Hospital Trust, Tønsberg, Norway
Pål Suhrke
Department of Haematology, Oslo University Hospital, Oslo, Norway
Geir E. Tjønnfjord
Department of Oncology, Førde Hospital Trust, Førde, Norway
Liv J. Vassbotn
K.T. wrote the manuscript and integrated edits from other authors. Important discussions and contributions to the initiatives described were made by all authors. All authors have approved the final version of the text.